Clin2
NCT06721949Possibly a fitRecruiting

Taurine for long COVID symptoms

Long COVID

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial tests if taking taurine, a natural amino acid supplement, can help reduce lingering symptoms of COVID-19 that last for months. If you have had COVID-19 and still have symptoms like fatigue or brain fog for at least 2 months after 3 months from your infection, this study might be for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
300 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • 18 years or older
  • Had COVID-19 (confirmed by test or suspected by doctor) at least 3 months ago
  • Have had lingering COVID symptoms for at least 2 months, starting from at least 3 months after your infection
  • Have current lingering symptoms at the start of the study
  • Not currently taking certain medications for fatigue or thinking problems (like modafinil, ADHD stimulants) for the past 4 weeks

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07682402Not yet recruiting· Phase 1/Phase 2
Taurine for teens with long COVID symptoms

This trial tests if taurine, a natural supplement, can help teenagers who still have symptoms like fatigue or brain fog months after a COVID infection. It aims to see if taking taurine reduces these lingering symptoms.

NCT07397910Not yet recruiting
A natural compound for long COVID inflammation

This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.

Murcia
NCT07597902Not yet recruiting· Phase 2
Testing antivirals to help Long COVID symptoms

This study tests whether medicines that fight viruses (similar to those used for herpes or COVID) can reduce Long COVID symptoms like fatigue and brain fog. Researchers believe lingering viruses or viral reactivation may drive Long COVID, and this trial will see if antiviral drugs help.

New York, New York
NCT06511063Recruiting· Phase 2
Antiviral trial for treating long covid symptoms

This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.

New York, New York
NCT06452095Recruiting
Hyperbaric oxygen therapy for long COVID brain fog

This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) helps with long COVID symptoms, especially brain fog and thinking problems. It may be an option if you have had lingering symptoms for at least 2 months and can travel to one of the study sites.

Toronto, Ontario
NCT06928272Recruiting· Phase 3
Long COVID drug study for adults 18 to 65

This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.

San Diego, California

Hear when a new Long COVID trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.